The effect of theophylline on apnoea and hypoxaemic episodes in the premature neonate during the 1st 3 days after birth

Annals of Tropical Paediatrics

Volumn 18, Issue 3, 1998, Pages 217-224

  Du Preez, M J ^a   Botha, J H ^a   McFadyen, M L ^b   Adhikari, M ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; THEOPHYLLINE;

APNEA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; FEMALE; HUMAN; HYPOXEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEWBORN; NOSE AIRFLOW; OXYGEN SATURATION; PREMATURITY; PULSE RATE;

EID: 0031754840     PISSN: 02724936     EISSN: None     Source Type: Journal    
DOI: 10.1080/02724936.1998.11747950     Document Type: Article

References (46)

1. Poets CF, Stebbens VA, Richard D, Southall DP. Prolonged episodes of hypoxemia in preterm infants undetectable by cardiorespiratory monitors. Pediatrics 1995; 95:860-3.
2. Poets CF, Samuels MP, Southall DP. Potential role of intrapulmonary shunting in the genesis of hypoxemic episodes in infants and young children. Pediatrics 1992; 90:385-91.
3. Richard D, Poets CF, Neale S, Stebbbens VA, Alexander JR, Southall DP. Arterial oxygen saturation in preterm neonates without respiratory failure. J Pediatr 1993; 123:963-8.
4. Kuzemko JA, Paala J. Apnoeic attacks in the newborn treated with aminophylline. Arch Dis Child 1973; 48:404-6.
5. Shannon DC, Gotay F, Stein IM, Rogers MC, Todres D, Moylan FMB. Prevention of apnea and bradycardia in low-birth weight infants. Pediatrics 1975; 55:589-94.
6. Peabody JL, Neese AL, Philip AGS, Lucey JF, Soyka LF. Transcutaneous oxygen monitoring in aminophylline-treated apneic infants. Pediatrics 1978; 62:698-701.
7. Myers TF, Milsap RL, Krauss AN, Auld PAM, Reidenberg MM. Low-dose theophylline therapy in idiopathic apnea of prematurity. J Pediatr 1980; 96:99-103.
8. Milsap RL, Krauss AN, Auld PAM. Oxygen consumption in apnoeic premature infants after low-dose theophylline. Clin Pharmacol Ther 1980; 28:536-40.
9. Roberts JL, Mathew OP, Thach BT. The efficacy of theophylline in premature infants with mixed and obstructive apnea and apnea associated with pulmonary and neurologic disease. J Pediatr 1982; 100:968-70.
10. Finer NN, Peters KL, Duffley LM, Coward JH. An evaluation of theophylline for idiopathic apnea of infancy. Dev Pharmacol Ther 1984; 7:73-81.
11. Brouard C, Moriette G, Murat I, et al. Comparative efficacy of theophylline and caffeine in the treatment of idiopathic apnea in premature infants. Am J Dis Child 1985; 139:698-700.
12. Bairam A, Boutroy M, Badonnel Y, Vert P. Theophylline vs caffeine: comparative effects in treatment of idiopathic apnea in the preterm infant. J Pediatr 1987; 110:636-9.
13. Muttitt SC, Tierney AJ, Finer NN. The dose response of theophylline in the treatment of apnea of prematurity. J Pediatr 1988; 112:115-21.
14. Harrison H Jr. Apnea of prematurity: theophylline vs caffeine. Alaska Med 1992; 34:173-6.
15. Scanlon JEM, Chin KC, Morgan MEI, Durbin GM, Hale KA, Brown SS. Caffeine or theophylline for neonatal apnoea? Arch Dis Child 1992; 67:425-8.
16. Sims ME, Yau G, Rambhatla S, Cabal L, Wu PYK. Limitations of theophylline in the treatment of apnea of prematurity. Am J Dis Child 1985; 139:567-70.
17. Merchant RH, Sakhalkar VS, Ashavaid TF. Prophylactic theophylline infusion for the prevention of apnea of prematurity. Indian Pediatr 1992; 29:1359-63.
18. Poets CF, Samuels MP, Southall DP. Epidemiology and pathophysiology of apnoea of prematurity. Biol Neonate 1994; 65:211-19.
19. Samuels MP, Poets CF, Stebbens VA, Alexander JA, Southall DP. Oxygen saturation and breathing patterns in preterm infants with cyanotic episodes. Acta Paediatr 1992; 81:875-80.
20. Southall DP, Noyes JP, Poets CF, Samuels MP. Mechanisms for hypoxaemic episodes in infancy and early childhood. Acta Paediatr 1993; 389(Suppl):60-2.
21. Bolivar JM, Gerhardt T, Gonzalez A, et al. Mechanisms for episodes of hypoxemia in preterm infants undergoing mechanical ventilation. J Pediatr 1995; 127:767-73.
22. Parkin JM, Hey EN, Clowes JS. Rapid assessment of gestational age at birth. Arch Dis Child 1976; 51:259-63.
23. Lubchenco LO, Hansman C, Boyd E. Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26-42 weeks. Pediatrics 1966; 37:403-8.
24. Thach BT, Stark AR. Spontaneous neck flexion and airway obstruction during apneic spells in preterm infants. J Pediatr 1979; 94:275-81.
25. Ruggins NR, Milncr AD. Site of upper airway obstruction in preterm infants with problematical apnoea. Arch Dis Child 1991; 66:787-92.
26. Long JG, Philip AGS, Lucey JF. Excessive handling as a cause of hypoxemia. Pediatrics 1980; 65:203-7.
27. Ruggins NR. Pathophysiology of apnoea in preterm infants. Arch Dis Child 1991; 66:70-3.
28. Abu-Osba YK, Brouillette RT, Wilson SL, Thach BT. Breathing pattern and transcutaneous oxygen tension during motor activity in preterm infants. Am Rev Respir Dis 1982; 125:382-7.
29. Barrington K, Finer N. The natural history of the appearance of apnea of prematurity. Pediatr Res 1991; 29:372-5.
30. Hertzberg T, Lagercrantz H. Postnatal sensitivity of the peripheral chemoreceptors in newborn infants. Arch Dis Child 1987; 62:1238-41.
31. Hertzberg T, Hellström S, Lagercrantz H, Pequignot JM. Development of the arterial chemoreflex and turnover of carotid body catecholamines in the newborn rat. J Physiol 1990; 425:211-25.
32. Rylance GW. Neonatal pharmacology. In: Roberton NRC, ed. Textbook of Neonatology. Edinburgh: Churchill Livingstone, 1992; 1193-211.
33. Chen Y, Liou C, Tsai C, Yeh T. Effect of aminophylline on brain stem auditory evoked potentials in preterm infants. Arch Dis Child 1994; 71:F20-3.
34. Upton CJ, Milner AD, Stokes GM. Apnoea, bradycardia, and oxygen saturation in preterm infants. Arch Dis Child 1991; 66:381-5.
35. Bucher HU, Duc G. Does caffeine prevent hypoxaemic episodes in premature infants? A randomized control trial. Eur J Pediatr 1988; 147:288-91.
36. Poets CF, Stebbens VA, Alexander JR, Arrowsmith WA, Salfield SAW, Southall DP. Oxygen saturation and breathing patterns in infancy. 2: Preterm infants at discharge from special care. Arch Dis Child 1991; 66:574-8.
37. Gerhardt T, McCarthy J, Bancalari E. Effect of aminophylline on respiratory center activity and metabolic rate in premature infants with idiopathic apnea. Pediatrics 1979; 63:537-42.
38. Sherman MS, Lang DM, Matityahu A, Campbell D. Theophylline improves measurements of respiratory muscle efficiency. Chest 1996; 110:1437-42.
39. Aubier M. Effect of theophylline on diaphragmatic and other skeletal muscle function. J Allergy Clin Immunol 1986; 78:787-92.
40. Heyman E, Ohlsson A, Heyman Z, Fong K. Apnoea in preterm infants: role of aminophylline and diaphragmatic contractility. Pediatr Res 1989; 25:313A.
41. Bruce RD, Damall RA, Althaus JS. Aminophylline reduces hypoxic ventilatory depression without increasing catecholamines. Pediatr Pulmonol 1986; 2:218-24.
42. Walther FJ, Sims ME, Siassi B, Wu PYK. Cardiac output changes secondary to theophylline therapy in preterm infants. J Pediatr 1986; 109:874-6.
43. Sevanian A, Gilden C, Kaplan SA, Barrett CT. Enhancement of fetal lung surfactant production by aminophylline. Pediatr Res 1979; 13: 1336-40.
44. Granati B, Grella PV, Pettenazzo A, Di Lenardo L, Rubaltelli FF. The prevention of respiratory distress syndrome in premature infants: efficacy of antenatal aminophylline treatment vs prenatal glucocorticoid administration. Pediatr Res 1984; 18:324A.
45. Hegyi T, Hiatt IM, Stile IL, Zolfaghari S. Effects of postnatal aminophylline on the course of respiratory distress syndrome in premature infants. Clin Ther 1986; 8:439-49.
46. Miall-Allen VM, de Vries LS, Whitelaw AGL. Mean arterial blood pressure and neonatal cerebral lesions. Arch Dis Child 1987; 62:1068-72.